Related Experiment Video
Updated: Aug 1, 2026

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte
K S Kilgore1, E Schmid, T P Shanley
1Department of Pathology, University of Michigan Medical School, Ann Arbor 48109-0602, USA.
Abstract:
Activation of the complement cascade and subsequent assembly of the membrane attack complex (MAC) occur in a number of pathophysiological settings. When formed on the surface of endothelial cells in sublytic concentrations, the MAC can induce a number of proinflammatory activities, including the secretion of soluble mediators (eg, interleukin (IL)-8 and monocyte chemoattractant protein (MCP)-1) and the up-regulation of cell surface adhesion molecules. Available data indicate that MAC-induced cell activation may occur through several complex signal transduction pathways, but little is known about the intranuclear mechanisms by which complement-derived products promote the up-regulation of inflammatory mediators. Using purified distal complement proteins (C5-9) to assemble functional MAC on early-passage human umbilical vein endothelial cells (HUVECs), we examined mechanisms of MCP-1 and IL-8 induction. Formation of sublytic concentrations of MAC promoted an increase in nuclear factor (NF)-kappa B DNA binding activity within 60 minutes as determined by serial electrophoretic mobility shift assay. Cytosolic to nuclear translocation of NF-kappa B was confirmed by Western immunoblot and immunocytochemical analyses. Formation of the C5b-8 complex also promoted NF-kappa B translocation but to a lesser degree than observed in HUVECs containing complete MAC. No cytosolic to nuclear translocation of the p65 NF-kappa B subunit was observed in unstimulated HUVECs or in cells incubated with the MAC components devoid of C7. Preincubation of HUVECs with pyrrolidine dithiocarbamate prevented MAC-induced increases in IL-8 and MCP-1 mRNA concentrations and protein secretion. A direct cause and effect linkage between MAC assembly and NF-kappa B activation was established through examination of the pharmacological effect of the peptide SN50 on IL-8 and MCP-1 expression. SN50 is a recently engineered 26-amino-acid peptide that contains a lipophilic cell-membrane-permeable motif and a nuclear localization sequence that specifically competes with the nuclear localization sequence of the NF-kappa B p50 subunit. This study provides direct in vitro evidence that the distal complement system (MAC) can promote proinflammatory endothelial cell activation, specifically, increases in IL-8 and MCP-1 mRNA concentrations and protein secretion, and that cytosolic to nuclear translocation of NF-kappa B is necessary for this response.
Insights
The membrane attack complex (MAC) activates endothelial cells, increasing inflammatory mediators like IL-8 and MCP-1. This process requires nuclear factor-kappa B (NF-κB) translocation, highlighting a key mechanism in complement-driven inflammation.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- The complement cascade and membrane attack complex (MAC) are implicated in various diseases.
- MAC on endothelial cells can trigger pro-inflammatory responses, but intracellular mechanisms are unclear.
- Understanding how complement activation leads to inflammation is crucial for therapeutic development.
Purpose of the Study:
- To investigate the intranuclear mechanisms of MAC-induced inflammation in endothelial cells.
- To determine the role of nuclear factor-kappa B (NF-κB) in MAC-mediated upregulation of IL-8 and MCP-1.
- To establish a direct link between MAC assembly and inflammatory mediator production.
Main Methods:
- Functional MAC assembly on human umbilical vein endothelial cells (HUVECs) using purified complement proteins (C5-9).
- Electrophoretic mobility shift assay (EMSA) to assess NF-κB DNA binding activity.
- Western immunoblot and immunocytochemistry to confirm NF-κB translocation.
- Pharmacological inhibition using pyrrolidine dithiocarbamate and the SN50 peptide to block NF-κB activation.
Main Results:
- Sublytic MAC formation significantly increased NF-κB DNA binding activity and translocation to the nucleus within 60 minutes.
- Complete MAC assembly induced greater NF-κB translocation than partial complexes (C5b-8).
- Inhibition of NF-κB activation prevented MAC-induced increases in IL-8 and MCP-1 mRNA and protein secretion.
Conclusions:
- The distal complement system, specifically MAC, directly promotes pro-inflammatory endothelial cell activation.
- Cytosolic to nuclear translocation of NF-κB is a necessary intracellular event for MAC-induced IL-8 and MCP-1 expression.
- This study elucidates a critical molecular pathway linking complement activation to endothelial cell-driven inflammation.
Related Concept Videos
Inflammation
Complement System
Acute Inflammation I: Inflammatory Response
Acute Inflammation II: Cellular Phase
Acute Inflammation III: Local and Systemic Effects
Chronic Inflammation: Introduction

